Evelo Biosciences, Inc. Common Stock
EVLO
EVLO: Evelo Biosciences Inc is a United States-based biotechnology company. It is engaged in discovering and developing a new class of orally delivered investigational medicines that are intended to act on cells in the small intestine to produce therapeutic effects throughout the body. Its lead product candidate under development is EDP1815, which is for the treatment of inflammatory diseases and the hyperinflammatory response associated with COVID-19. Other products in the pipeline include EDP1867 and EDP2939 for the treatment of inflammatory disease and EDP1908 for the treatment of cancer.
moreShow EVLO Financials
Recent trades of EVLO by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by EVLO's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiome Jun. 13, 2023
-
Patent Title: Probiotic compositions containing clostridiales for inhibiting inflammation Mar. 28, 2023
-
Patent Title: Probiotic compositions containing clostridiales for inhibiting inflammation Mar. 21, 2023
-
Patent Title: Bacterial extracellular vesicles Dec. 13, 2022
-
Patent Title: Compositions and methods for treating immune disorders using immune modulating Mar. 08, 2022
-
Patent Title: Treating cancer using a blautia strain Feb. 08, 2022
-
Patent Title: Compositions and methods for treating cancer and immune disorders using Aug. 17, 2021
-
Patent Title: Probiotic and prebiotic compositions, and methods of use thereof for modulation of the microbiome Apr. 20, 2021
-
Patent Title: Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease Dec. 22, 2020
-
Patent Title: Compositions and methods of treating cancer using Oct. 06, 2020
-
Patent Title: Pharmaceutical compositions comprising a Jul. 07, 2020
-
Patent Title: Method of treating cancer using Mar. 03, 2020
-
Patent Title: Compositions and methods for treating disease using a Dec. 03, 2019
-
Patent Title: Probiotic and prebiotic compositions, and methods of use thereof for treatment and prevention of graft versus host disease Mar. 28, 2017
Federal grants, loans, and purchases
Followers on EVLO's company Twitter account
Number of mentions of EVLO in WallStreetBets Daily Discussion
Recent insights relating to EVLO
Recent picks made for EVLO stock on CNBC
ETFs with the largest estimated holdings in EVLO
Flights by private jets registered to EVLO